Oral balsalazide (Colazal) for ulcerative colitis.
D015746:Abdominal Pain / Q000139:chemically induced; D000284:Administration, Oral; D000636:Aminosalicylic Acids / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D000897:Anti-Ulcer Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004342:Drug Hypersensitivity / Q000209:etiology; D004347:Drug Interactions; D019804:Mesalamine; D009325:Nausea / Q000139:chemically induced; D010659:Phenylhydrazines; D016032:Randomized Controlled Trials as Topic
D000636:Aminosalicylic Acids; D000897:Anti-Ulcer Agents; D010659:Phenylhydrazines; D019804:Mesalamine; C038637:balsalazide